Purpura, Thrombocytopenic, Idiopathic

Displaying 1 - 4 of 4CSV
Kim, T. O., Geris, J. M., Flanagan, J. M., Grace, R. F., Lambert, M. P., O’Farrell, C., Rose, M. J., Shimano, K. A., Niss, O., Neunert, C., Nakano, T. A., MacMath, D., Dinu, B., Kirk, S. E., Neufeld, E. J., Despotovic, J. M., Scheurer, M. E., & Grimes, A. B. (2024). Genetic variants in canonical Wnt signaling pathway associated with pediatric immune thrombocytopenia. Blood Advances, 8(21), 5529–5538. https://doi.org/10.1182/bloodadvances.2024012776
Publication Date
Neunert, C. E., Arnold, D. M., Grace, R. F., Kuhne, T., McCrae, K. R., & Terrell, D. R. (2024). The 2022 review of the 2019 American Society of Hematology guidelines on immune thrombocytopenia. Blood Advances, 8(13), 3578–3582. https://doi.org/10.1182/bloodadvances.2023012541
Publication Date
Neunert, C., Heitink‐Polle, K. M. J., & Lambert, M. P. (2023). A proposal for new definition (s) and management approach to paediatric refractory ITP: Reflections from the Intercontinental ITP Study Group. British Journal of Haematology, 203(1), 17–22. Portico. https://doi.org/10.1111/bjh.19072
Publication Date
Hillier, K., Rothman, J. A., Klaassen, R. J., Neunert, C., Rose, M. J., Grace, R. F., & Lambert, M. P. (2022). SARS‐CoV‐2 vaccination in pediatric patients with immune thrombocytopenia. Pediatric Blood & Cancer, 69(7). Portico. https://doi.org/10.1002/pbc.29760
Publication Date